Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02378779
Other study ID # GETUP
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date April 22, 2016
Est. completion date April 22, 2018

Study information

Verified date October 2020
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Many male patients complain about their ejaculation: 21-30% of men aged between 18 and 59 have admitted suffering from a decrease in, or loss of control of, their ejaculation. The quality of life of patients and their partners is impaired compared to men not suffering from premature ejaculation. Economically, the impact of the disease are significant. In the year preceding the detection of premature ejaculation patients visit twice their physician. The majority of men interviewed anonymously, in their General Practitioner's ( GP's) waiting room, considered it important to talk with their GP about their sexual concerns. Almost half of them preferred that their GP initiate any discussions about sexuality. More than two thirds of the respondents would have liked their GP to signal his or her open-mindedness by directly addressing sexual topics during the consultation. In 2008 a qualitative study brought to the fore the strategies used by GPs to initiate the discussion on premature ejaculation . GPs who mentioned premature ejaculation with their patient described three attitude-related strategies and three investigative strategies.


Recruitment information / eligibility

Status Terminated
Enrollment 132
Est. completion date April 22, 2018
Est. primary completion date April 22, 2018
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Male patients overbetween 18 and 80 years old and - Patients consulting for a sexual, urogenital or psychological reason according to Interntational Classification of Primary Care (ICPC-2) will be included. Exclusion Criteria: - Patients consulting for Aanother reason for visiting thethan urogenital pattern, sexual or psychological - Nonunderstanding of the French language - Patients with psychiatric disorders affecting judgement - Patient refusal to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Questionary SF12 and PEDT (Premature Ejaculation Diagnostic Tool)
The SF-12 was designed to measure general health status from the patient's point of view (12 questions are asking to the patients) and the PEDT questionnaire is a self-assessment questionnaire to diagnose premature ejaculation (5 questions are asking to the patients).
Total attention
Total attention of the GP to approach the subject of premature ejaculation during all the consultation
Humour
Use the humour to approach the subject of premature ejaculation
Take the drama out
Take the drama out to approach the subject of premature ejaculation
Question about premature ejaculation
Question about premature ejaculation during the GP consultation
Symptoms of premature ejaculation
GP's observation about signs of premature ejaculation
Help to verbalize
Help for the patient to speak about premature ejaculation

Locations

Country Name City State
France Cabinet médical Ambert
France Cabinet médical - 89 Bis Rue de la Calade Assas
France Cabinet médical Augerolles
France Cabinet médical Avermes
France Cabinet médical - Esplanade Mitterrand 5 Bellerive-sur-Allier
France Cabinet de médecine générale Brest
France Cabinet du 122 rue Paul Masson Brest
France Cabinet médical Place J. London Brest
France Cabinet médical Clarensac
France Cabinet médical Fleury
France Pôle universitaire de Lanmeur Lanmeur
France Cabinet médical Le Mayet de Montagne
France Cabinet médical Le Puy En Velay
France Cabinet médical Lempdes sur Allagnon
France Cabinet médical du 38 Bd 1848 Narbonne
France Cabinet de médecine générale Ondres
France Cabinet de médecine générale Pont de Buis Les Quimerch
France Cabinet médical du 5 Descente des Oliviers Restinclières
France Cabinet médical Saint Nicolas du Pelem
France Groupe médical Tourren Saint Vincent de Tyrosse
France Cabinet de médecine générale Saubrigues
France Cabinet médical Thézan Les Béziers
France Cabinet médical - 39 rue Saint Philibert Trégunc

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The impact of training general practitioners in communication skills The impact of training general practitioners in communication skills on the rate of patients bringing up the topic of premature ejaculation with their GP. To measure the proportions of patients bringing up the topic of premature ejaculation with their GP, the GPs in the two groups were asked to fill in a questionnaire after the consultation on whether the topics tackled were genital, urinary or psychological. The aim of detailing the different topics broached was to avoid contamination bias in the control group. Day 0 - 4 weeks
Secondary Evaluation of quality of life The quality of life will be evaluated with the SF-12 health assessment scale. The SF-12 was designed to measure general health status from the patient's point of view. The SF-12 includes 8 concepts commonly represented in health surveys: physical functioning, role functioning physical, bodily pain, general health, vitality, social functioning, role functioning emotional, and mental health. Day 0 - 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT02232425 - IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE) Phase 2
Completed NCT01439984 - Trial of PED-1 in Male Patients With Premature Ejaculation Phase 3
Completed NCT01184105 - A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation Phase 1
Completed NCT01203202 - Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation Phase 2
Completed NCT03942367 - Evaluation of the Safety and Effectiveness of the vPatch Device N/A
Recruiting NCT06425211 - Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation. N/A
Completed NCT02939495 - The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy Phase 4
Completed NCT02572037 - Research and Clinical Value of New Classification for Premature Ejaculation: Multi-Center Research
Recruiting NCT02581826 - Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation Phase 2
Terminated NCT00983736 - Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation Phase 3
Completed NCT00549211 - A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296. Phase 1
Completed NCT00556478 - Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation Phase 2/Phase 3
Not yet recruiting NCT05556083 - Sildenafil Added Effect in Dapoxetine Non-responding Mono-symptomatic Premature Ejaculation (PE) Phase 2
Completed NCT03304808 - Efficacy of a New Behavioral Treatment for Premature Ejaculation Using a Masturbation Aid Device: Star-Stop 3.0 N/A
Completed NCT00861484 - Proof of Mechanism in ELT Phase 1
Completed NCT02984592 - Effect of Exercise on Premature Ejaculation N/A
Recruiting NCT02571101 - A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation Phase 2
Completed NCT03174470 - Safety Demonstration of Increasing Intensities of Electrical Stimulation Delivered to The Bulbospongiosus Muscle N/A
Completed NCT02794454 - A Study to Evaluate Efficacy of Investigational Product HeezOn Ultra -1/ HeezOn Ultra-2 on Male Sexual Health N/A
Completed NCT02297152 - A New Treatment for Premature Ejaculation? N/A